Proteasome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation

Molecular Endocrinology

Volumn 13, Issue 9, 1999, Pages 1522-1534

  Alarid, Elaine T ^a,b   Bakopoulos, Natalie ^a   Solodin, Natalia ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Dept of Physiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROTEASOME; PROTEINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033304776     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.9.0337     Document Type: Article

References (50)

1. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity
2. The limits of the cellular capacity to mediate an estrogen response
3. Expression of estrogen receptor and its messenger ribonucleic acid in the MCF-7 cell line: Multiparametric analysis of its processing and regulation by estrogen
4. Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression
5. The dynamics of intracellular estrogen receptor regulation as influenced by 17β-estradiol
6. Nuclear mechanism of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing
7. Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation
8. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines
9. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors
10. Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: An inverse correlation to progesterone receptors
11. Regulation of the estrogen receptor in MCF-7 cells by estradiol
12. Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells
13. Oligonucleotide squelching reveals the mechanism of estrogen receptor autologous down-regulation
14. Reduction in the expression and action of transforming growth factor b1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary
15. Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests only a small pool of estrogen receptors is required for growth
16. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique
17. Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo
18. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen
19. Anomalous behavior of protein synthesis inhibitors on the turnover of the estrogen receptor as measured by density labeling
20. The antiestrogen ICI 182,780 disrupts estrogen receptor nucleocytoplasmic shuttling
21. Estradiol-stimulated proteolytic cleavage of the estrogen receptor in mouse uterus
22. Partial characterization of protease(s) in human breast cancer cytosols that can degrade estrogen and progesterone receptors selectively
23. Estrogen binding proteins of calf uterus
24. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
25. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover
26. Nuclear localization of unoccupied estrogen receptor
27. The E6 oncoprotein encoded by human papillomavirus types 18 and 18 promotes the degradation of p53
28. Degradation of the myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: Regulation by specific DNA-binding
29. Phosphorylation of nuclear MyoD is required for its rapid degradation
30. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
31. The short-lived MATα2 transcriptional regulator is ubiquitinated in vivo
32. Proteasomal regulation of nuclear receptor corepressor-mediated repression
33. Ubiquitination of the rat uterine estrogen receptor: Dependence on estradiol
34. Proteasome-dependent degradation of the human estrogen receptor
35. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
36. Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary
37. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue
38. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
39. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells
40. Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signaling cascade and c-fos immediate early gene transcription
41. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells
42. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
43. Phospholipase C β and membrane action action of calcitrol and estradiol
44. Cell signaling and estrogens in female rat osteoblasts; A possible involvement of unconventional non-nuclear receptors
45. Nongenomic effects of 17β-estradiol on maturing human oocytes: Relationship to oocyte developmental potential
46. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding
47. Antisera to a synthetic peptide recognize native and denatured rat estrogen receptors
48. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
49. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen